Skip to content
Open access

Reversal of Polyendocrine Metabolic Ovarian Syndrome (PMOS) Features Through Ayurvedic Management and Yoga: A Case Study

Sep 2026 · Journal of Ayurveda and Integrated Medical Sciences · 0 citations · 7 references

TL;DR

A case of a 20 year-old female with a 2-year history of irregular menses and an obesity issue and a proper, customized ayurvedic treatment for PMOS, which showed normalization in ovarian size and no signs of peripheral follicles, indicating an improvement in PMOS.

Abstract

Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a prevalent endocrine-metabolic disorder in reproductive age with an estimated global increasing rate ranging from 10-15% due to modern lifestyle changes. The term PMOS emphasizes the multisystem endocrine, metabolic, and ovarian dimensions of the condition rather than implying that true ovarian cysts are the defining feature. In this case study, we are presenting a case of a 20 year-old female with a 2-year history of irregular menses and an obesity issue (25% rise from normal weight). The ultrasound revealed bulky ovaries with echogenic stroma and a few peripherally placed follicles. The patient underwent a proper, customized ayurvedic treatment, including internal medicine, Yogabasti, diet, lifestyle modification, and Yoga. Over a period of nine months, the ultrasound scan report showed normalization in ovarian size and no signs of peripheral follicles, indicating an improvement in PMOS. Additionally, the patient experienced considerable improvement, including regular menstrual cycles and a normal weight (reducing from 70kg to 56kg). This individualized Ayurvedic approach highlights the potential effectiveness of Ayurvedic management for PMOS.  

Read PDF

Similar papers

Review Open access Aug 2026

Recent advances in polyendocrine metabolic ovarian syndrome, formerly polycystic ovary syndrome, with emphasis on endocrine and metabolic dysfunction and cardiovascular risk

Recognizing PMOS as an early-life marker of cardiometabolic disease highlights opportunities for earlier diagnosis, prevention, and individualized risk stratification, supporting integrated, patient-centered care across the life course.

M. Forslund, J. Melin, A. Joham et al. · 0 citations
Review Sep 2026

Polyendocrine Metabolic Ovarian Syndrome (PMOS): Renaming PCOS from Describing an Ovarian Disorder to a Systemic Disease with Multifaceted Metabolic Foundations

Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders among women of reproductive age. Evolving diagnostic criteria—from the initial Stein–Leventhal report through the National Institutes of Health (NIH), Rotterdam, and Androgen Excess and PCOS Society (AE PCOS) frameworks, alo...

Mina Amiri, N. Panahi, M. Amoli et al. · 0 citations
Open access Aug 2026

Lifestyle modifications before medicines: early intervention in adolescent polyendocrine metabolic ovarian syndrome

Dealing with PMOS is challenging since normal pubertal development overlaps typical features of syndrome, and healthcare providers should make the diagnosis of PMOS on evidence-based guidelines to prevent delayed, under diagnosis or over diagnosis.

Neeti Gupta, M. Agrawal, Suchismita Das · 0 citations
Review Open access Sep 2026

FROM PCOS TO PMOS: A CRITICAL REVIEW OF TERMINOLOGY, MULTISYSTEM PATHOLOGY, AND CLINICAL IMPLICATIONS

Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine and metabolic disorders among women of reproductive age worldwide, with an estimated global prevalence of 8-13% depending on the diagnostic criteria used. The term Polycystic Ovary Syndrome is a common clinical finding, but has been increasingly criti...

Mahi Killekar · 0 citations
Review Open access Sep 2026

From Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome: A Systematic Search and Historical Account of the Renaming of PCOS.

Polyendocrine metabolic ovarian syndrome (PMOS) is one of the most common endocrine conditions affecting hundreds of millions of women globally. The former name polycystic ovary syndrome (PCOS) was inaccurate, underpinning the robust nomenclature change process. This review historically traces renaming efforts up to, i...

H. Teede, Saeede Saadati, Rachel Morman et al. · 0 citations
Open access Sep 2026

Study of different aspects of polyendocrine metabolic ovarian syndrome in females of reproductive age group

Background: PMOS is most common hormonal disorder in females of reproductive age group. In PMOS many pearl sized cysts are formed in the ovaries. These cysts contain immature eggs. High LH, low FSH, high Testosterone in PMOS causes changes in physical appearance, irregularity in menstrual cycle and if not treated in ti...

Vani Bansal, Palak Meena, Kunal Bansal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.